Pharmacokinetic interactions between Eslicarbazepine Acetate and other anti-epileptic drugs as compared to Oxcarbazepine and Carbamazepine.

Trial Profile

Pharmacokinetic interactions between Eslicarbazepine Acetate and other anti-epileptic drugs as compared to Oxcarbazepine and Carbamazepine.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Dec 2017

At a glance

  • Drugs Carbamazepine (Primary) ; Eslicarbazepine acetate (Primary) ; Oxcarbazepine (Primary)
  • Indications Partial epilepsies
  • Focus Pharmacokinetics
  • Most Recent Events

    • 11 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top